(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMBINAÇÃO DE DCC-3116 E INIBIDORES DA VIA MAPKAP PARA USO NO TRATAMENTO DE CÂNCER

Em AnáliseInvention PatentPCT · US2023073071

Application data

Invention Patent COMBINAÇÃO DE DCC-3116 E INIBIDORES DA VIA MAPKAP PARA USO NO TRATAMENTO DE CÂNCER de DECIPHERA PHARMACEUTICALS, LLC — IPC A61K 31/4184
Invention Patent COMBINAÇÃO DE DCC-3116 E INIBIDORES DA VIA MAPKAP PARA USO NO TRATAMENTO DE CÂNCER de DECIPHERA PHARMACEUTICALS, LLC — IPC A61K 31/4184. Drawing published by the INPI in the Industrial Property Gazette.

Number

112025004075

Type

Invention Patent

Filing

08/29/2023

Publication

09/02/2025

PCT

US2023073071

Progress at the INPI

Examination not yet requested
  1. Filing08/29/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 08/29/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:08/29/2026(4 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 09/02/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

DECIPHERA PHARMACEUTICALS, LLC

US

See this company's full portfolio

Inventors

B. S. (pessoa física)

US

D. F. (pessoa física)

US

F. R. (pessoa física)

US

G. A. (pessoa física)

US

M. B. (pessoa física)

US

M. S. (pessoa física)

US

R. S. (pessoa física)

US

Technical data

Priority claims

US

63/374,451 · 09/02/2022

US

63/403,477 · 09/02/2022

US

63/478,777 · 01/06/2023

US

63/478,782 · 01/06/2023

US

63/493,825 · 04/03/2023

US

63/493,828 · 04/03/2023

US

63/495,693 · 04/12/2023

US

63/495,694 · 04/12/2023

US

63/508,646 · 06/16/2023

US

63/508,652 · 06/16/2023

Abstract

COMBINAÇÃO DE DCC-3116 E INIBIDORES DA VIA MAPKAP PARA USO NO TRATAMENTO DE CÂNCER. São descritos neste documento compostos que são inibidores de autofagia e seu uso no tratamento de distúrbios tais como cânceres.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

09/02/2025

RPI 2852

Alteração de dados cadastrais

#1.1

03/11/2025

RPI 2827

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.